VICTOR MAQUERA: Open Payments
NPI 1891786059 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,897 in 242 payments from 33 companies in 2025. Trend: 2023 $3,730 · 2024 $5,618 · 2025 $4,897
Food & beverage: $4,897
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $678 |
| Axsome Therapeutics, Inc. | 16 | $406 |
| PFIZER INC. | 19 | $362 |
| Novartis Pharmaceuticals Corporation | 18 | $361 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $322 |
| Biogen, Inc. | 12 | $285 |
| Lundbeck LLC | 15 | $274 |
| ARGENX US, INC. | 11 | $191 |
| EMD Serono, Inc. | 8 | $189 |
| Neurelis, Inc. | 8 | $174 |
Products named: KESIMPTA, HYQVIA, UBRELVY, VRAYLAR, NURTEC ODT, Sunosi, Symbravo, VYVGART HYTRULO.
Industry payments across FL — which companies pay providers there.
